Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
4.220
-0.100 (-2.31%)
At close: Dec 5, 2025, 4:00 PM EST
4.241
+0.021 (0.51%)
After-hours: Dec 5, 2025, 7:24 PM EST

Pyxis Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
263938047353-
Upgrade
Market Cap Growth
8.03%16.32%70.77%-86.78%--
Upgrade
Enterprise Value
206-32-32-136414-
Upgrade
Last Close Price
4.221.561.801.3410.97-
Upgrade
PS Ratio
92.335.75----
Upgrade
PB Ratio
3.810.770.630.291.35-
Upgrade
P/TBV Ratio
3.960.790.790.291.35-
Upgrade
Debt / Equity Ratio
0.280.170.170.120.000.12
Upgrade
Asset Turnover
0.020.10----
Upgrade
Quick Ratio
3.937.184.635.6914.692.19
Upgrade
Current Ratio
4.297.494.845.9014.902.20
Upgrade
Return on Equity (ROE)
-87.28%-62.76%-51.51%-57.19%-56.78%-101.15%
Upgrade
Return on Assets (ROA)
-34.33%-24.77%-26.10%-31.41%-30.03%-53.80%
Upgrade
Return on Capital (ROIC)
-39.41%-28.46%-30.76%-34.98%-32.45%-61.61%
Upgrade
Return on Capital Employed (ROCE)
-95.80%-47.00%-54.30%-68.70%-26.70%-199.50%
Upgrade
Earnings Yield
-36.95%-83.36%-92.53%-258.50%-21.50%-
Upgrade
FCF Yield
-27.54%-62.42%-97.10%-205.00%-10.15%-
Upgrade
Buyback Yield / Dilution
-13.72%-46.46%-20.80%-288.93%-724.14%-53.41%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q